MCM
BCRX icon

Moore Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Moore Capital Management’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-65,000
Closed -$746K – 469
2022
Q4 		$746K Buy
+65,000
New +$746K 0.02% 327